ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK

Purpose Genetic studies of multiple sclerosis (MS) susceptibility and severity have focused on populations of European ancestry. Studying MS genetics in other ancestral groups is necessary to determine the generalisability of these findings. The genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis (ADAMS) project aims to gather genetic and phenotypic data on a large cohort of ancestrally-diverse individuals with MS living in the UK. Participants Adults with self-reported MS from diverse ancestral backgrounds. Recruitment is via clinical sites, online (https://app.mantal.co.uk/adams) or the UK MS Register. We are collecting demographic and phenotypic data using a baseline questionnaire and subsequent healthcare record linkage. We are collecting DNA from participants using saliva kits (Oragene-600) and genotyping using the Illumina Global Screening Array V.3. Findings to date As of 3 January 2023, we have recruited 682 participants (n=446 online, n=55 via sites, n=181 via the UK MS Register). Of this initial cohort, 71.2% of participants are female, with a median age of 44.9 years at recruitment. Over 60% of the cohort are non-white British, with 23.5% identifying as Asian or Asian British, 16.2% as Black, African, Caribbean or Black British and 20.9% identifying as having mixed or other backgrounds. The median age at first symptom is 28 years, and median age at diagnosis is 32 years. 76.8% have relapsing–remitting MS, and 13.5% have secondary progressive MS. Future plans Recruitment will continue over the next 10 years. Genotyping and genetic data quality control are ongoing. Within the next 3 years, we aim to perform initial genetic analyses of susceptibility and severity with a view to replicating the findings from European-ancestry studies. In the long term, genetic data will be combined with other datasets to further cross-ancestry genetic discoveries.

[1]  D. V. van Heel,et al.  Polygenic risk score prediction of multiple sclerosis in individuals of South Asian ancestry , 2023, Brain communications.

[2]  E. Burchard,et al.  Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population , 2022, PloS one.

[3]  G. Giovannoni,et al.  Towards a global view of multiple sclerosis genetics , 2022, Nature Reviews Neurology.

[4]  M. Inouye,et al.  Transferability of genetic loci and polygenic scores for cardiometabolic traits in British Pakistani and Bangladeshi individuals , 2022, Nature Communications.

[5]  F. Privé.  Using the UK Biobank as a global reference of worldwide populations: application to measuring ancestry diversity from GWAS summary statistics , 2021, bioRxiv.

[6]  L. Palaniappan,et al.  Improving diversity in medical research , 2021, Nature Reviews Disease Primers.

[7]  E. Burchard,et al.  The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States , 2020, Multiple sclerosis.

[8]  Simon C. Potter,et al.  Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility , 2019, Science.

[9]  M. McCarthy,et al.  Cohort Profile: East London Genes & Health (ELGH), a community-based population genomics and health study in British Bangladeshi and British Pakistani people , 2019, International journal of epidemiology.

[10]  E. Waubant,et al.  Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry , 2019, PLoS genetics.

[11]  H. Ullum,et al.  Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk , 2018, Cell.

[12]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[13]  J. Hobart,et al.  Validating the portal population of the United Kingdom Multiple Sclerosis Register. , 2018, Multiple sclerosis and related disorders.

[14]  D. Schaid,et al.  From genome-wide associations to candidate causal variants by statistical fine-mapping , 2018, Nature Reviews Genetics.

[15]  H. Ullum,et al.  Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk , 2018, Cell.

[16]  Joseph H. Marcus,et al.  Overexpression of the Cytokine BAFF and Autoimmunity Risk , 2017, The New England journal of medicine.

[17]  J. Wason,et al.  HLA associations in South Asian multiple sclerosis , 2016, Multiple sclerosis.

[18]  Calliope A. Dendrou,et al.  Class II HLA interactions modulate genetic risk for multiple sclerosis , 2015, Nature Genetics.

[19]  Jeffrey A. Cohen,et al.  An ImmunoChip study of multiple sclerosis risk in African Americans. , 2015, Brain : a journal of neurology.

[20]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[21]  P. D. De Jager,et al.  Genetic risk variants in African Americans with multiple sclerosis , 2013, Neurology.

[22]  Kerina H. Jones,et al.  The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS , 2012, BMC Medical Informatics and Decision Making.

[23]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[24]  M. Ban,et al.  Evaluation of the established non-MHC multiple sclerosis loci in an Indian population , 2011, Multiple sclerosis.

[25]  M. Daly,et al.  A high-density screen for linkage in multiple sclerosis. , 2005, American journal of human genetics.

[26]  G. Giovannoni,et al.  Modifiable Risk Factors for Multiple Sclerosis are Consistent Across Diverse Ethnic Backgrounds: A Nested Case-Control Study in a UK Population-Based Cohort , 2022, Social Science Research Network.